Navigation Links
Biota Initiates Drug Testing War against Common Cold

Human clinical trials of BTA798 anti-viral therapy for common cold have been initiated by Biota. The compound has already proven to be effective against the human rhinovirus // in lab experiments conducted on animal models. HRV currently accounts for nearly 50% and 75% of common cold suffered by adults and children respectively.

If successful results are obtained, the drug would soon be marketed. The researchers have however warned that it may not be a suitable treatment modality for everyone as common cold usually manifests as a self-limiting disease in healthy individuals. In addition, anti-viral medications are expensive compared to commonly used anti-biotics.

Patients who develop complications as a result of cold and other concommitant diseases would benefit the maximum from the new therapy. Examples include asthmatics, patients with chronic obstructive pulmonary disease (COPD), those undergoing chemotherapy or radiotherapy and immunocompromised individuals (HIV/AIDS patients, transplant recipients).

It has been found from U.S. statistical studies that 45 million bed days in hospitals could be atrributed to individuals who developded disease related complications as a result of common cold. It would be more sensible for these individulas to invest a few dollars for fighting the common cold rather than spending a considerble amount on hospital admission.

The health officials of Biota have remarked that the initiation of the first, independent clinical trial in Britain marked an important milestone in the company history. The results of the much-awaited trial would be released by December.


'"/>




Page: 1

Related medicine news :

1. Bird Flu: Orissa Initiates Protective Measures
2. Russia Initiates Mass Vaccination Of Poultry To Restrict Bird Flu
3. Government Initiates A Program To Curb HIV
4. First Vaccine Designed for Africa Cleared for Testing in Humans
5. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
6. Testing for blood sugar levels made easier
7. DNA Testing For More Accurate Results
8. SARS vaccine shows promise in Animal Testing
9. Testing Of Saliva May Predict Dental Caries
10. Diagnosing Sleep Apnea By Overnight Sleep Testing Method
11. Testing genes for disease does not cause harm to children of people with Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... Manhattan New york (PRWEB) , ... April 28, ... ... is pleased to announce that Aditya Patel M.D. has joined the revolutionary endoscopic ... fellowship training and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... their work assisting the Brooke Grove Foundation implement a Microsoft Dynamics GP solution ... Solutions, a leading ERP expert that specializes in long-term care, Brooke Grove now ...
(Date:4/28/2017)... ... ... Christie Medical Holdings, Inc. , with its market-leading vein finder ... a leader in infusion therapy and pain management. , Intravenous (IV) therapy plays ... patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals ...
(Date:4/27/2017)... Minnesota (PRWEB) , ... April 27, 2017 , ... ... and her husband Dan Gasby the 2017 Public Leadership in Neurology Award (PLINA). ... Woodruff, retired professional athlete Tedy Bruschi, Vice President Walter Mondale, actor Michael J. ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... PUNE, India , April 19, 2017 ... Type and Application, Forecast to 2022 report has covered and ... provides statistics and information on market size, shares and growth ... with major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and ...
Breaking Medicine Technology: